Campaigns. It is important that I continue to know the strength of feeling on an issue and I prefer to respond to every inquiry, but the sheer size of campaign correspondence means that it is hard to justify to the tax payer the cost and time taken for individual written replies, so regrettably I will no longer reply to every item of campaign correspondence.  I will  post a response to the campaign on the "Responses to campaigns" page of my website.

I am sorry to do this, as it is rather impersonal, but can see no other way of maintaining a good service for all my constituents unless I approach campaigns this way.


13 NOV 2018

MS

Thank you for taking the time to email me about multiple sclerosis.

I appreciate how challenging this condition can be to live with and I hope the following information on this topic from the Department of Health and Social Care is reassuring:

With more than 100,000 people across the UK diagnosed with multiple sclerosis, helping those suffering from this condition to lead as normal lives as possible remains a key commitment of the NHS.
Diagnosis in the early stages of multiple sclerosis can be difficult, with some of the symptoms often similar to other conditions. The National Institute for Health and Care Excellence (NICE) has produced guidelines to assist clinicians in diagnosing the condition. This guidance also provides clinicians with best practice for treating the many possible symptoms of multiple sclerosis, including mobility problems and fatigue.
Those suffering from multiple sclerosis may also have specific long-term social care needs. £9.4 billion in dedicated funding has been made available for adult social care through to 2020. Better integration between health and social care provision, creating genuinely people-centred coordinated care, is also required.
Almost £288 million has been spent on research into neurological conditions, including multiple sclerosis, since 2010 through the publicly-funded National Institute for Health Research (NIHR). With the NIHR's annual spending on neurological conditions up by more than £22 million since 2010.

Back to all posts